Tasly Pharmaceutical Group Co., Ltd (600535.SS)

Home
600535.SS
Financials

16.39 (CNY) • At close June 9, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue Numbers are in millions	8,498.142	8,674.014	8,593.2	7,951.957	13,576.115	18,998.31	17,989.536	16,094.15	13,945.497	13,227.512	12,580.279	11,108.066	9,301.456	6,569.665	4,651.591	3,992.645	3,434.216	2,794.906	2,414.345	1,465.867	1,301.841	1,055.761	929.786	684.556	391.618	253.013
Cost of Revenue Numbers are in millions	2,792.253	2,885.228	3,089.66	2,677.531	8,055.393	13,051.713	11,477.51	10,253.525	8,853.625	8,101.597	7,859.458	7,042.658	6,448.951	4,601.326	3,084.27	2,687.39	2,295.74	1,875.261	1,567.089	674.201	509.24	291.249	202.277	153.932	83.228	32.488
Gross Profit Numbers are in millions	5,705.889	5,788.787	5,503.539	5,274.426	5,520.722	5,946.597	6,512.026	5,840.625	5,091.872	5,125.916	4,720.821	4,065.408	2,852.505	1,968.339	1,567.321	1,305.255	1,138.476	919.645	847.257	791.666	792.602	764.513	727.509	530.624	308.39	220.526
Gross Profit Ratio Numbers are in millions	0.671	0.667	0.64	0.663	0.407	0.313	0.362	0.363	0.365	0.388	0.375	0.366	0.307	0.3	0.337	0.327	0.332	0.329	0.351	0.54	0.609	0.724	0.782	0.775	0.787	0.872
Reseach & Development Expenses Numbers are in millions	830.07	917.269	844.23	579.527	689.331	551.224	588.883	506.062	365.671	397.627	304.484	293.855	150.282	127.42	81.959	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	100.18	82.747	103.197	164.858	278.699	276.977	249.699	225.083	220.694	229.232	225.854	279.847	178.255	134.557	116.18	281.275	229.866	224.74	171.486	178.323	209.473	180.835	174.695	119.024	67.365	49.042
Selling & Marketing Expenses Numbers are in millions	2,090.482	2,098.421	2,879.547	2,906.471	2,672.468	2,764.817	2,790.393	2,534.861	2,362.303	1,990.927	1,821.897	1,552.778	1,185.552	786.394	631.624	565.829	496.046	408.304	352.772	317.556	325.899	385.803	381.324	261.853	141.827	80.437
SG&A Numbers are in millions	2,190.662	3,334.089	2,982.744	3,071.329	2,951.166	3,041.793	3,040.091	2,759.944	2,582.997	2,220.159	2,047.751	1,832.624	1,363.807	920.952	747.804	847.104	725.912	633.044	524.259	495.88	535.372	566.638	556.019	380.877	209.191	129.479
Other Expenses Numbers are in millions	1,609.235	309.549	302.954	311.367	346.227	355.586	9.821	-8.016	32.587	49.963	25.862	17.457	25.681	46.287	20.644	8.829	-1.542	11.868	2.364	0.665	-1.65	-1.297	-2.018	-1.49	1.465	-1.086
Operating Expenses Numbers are in millions	4,629.967	4,560.907	4,129.928	3,962.223	3,986.724	3,948.603	4,062.479	3,666.875	3,382.432	3,071.42	2,736.159	2,462.45	1,733.923	1,220.911	968.285	872.89	749.119	653.894	543.151	515.111	552.277	580.854	569.645	390.571	210.299	130.588
Operating Income Numbers are in millions	1,075.923	1,227.88	1,274.052	2,732.948	1,472.461	1,838.463	1,944.785	1,744.504	1,466.142	1,747.234	1,709.093	1,401.404	935.759	741.875	535.607	391.139	317.044	213.597	262.544	231.523	216.93	177.816	146.905	130.349	99.651	87.439
Operating Income Ratio Numbers are in millions	0.127	0.142	0.148	0.344	0.108	0.097	0.108	0.108	0.105	0.132	0.136	0.126	0.101	0.113	0.115	0.098	0.092	0.076	0.109	0.158	0.167	0.168	0.158	0.19	0.254	0.346
Total Other Income Expenses Net Numbers are in millions	-7.233	-6.783	-1,441.684	-9.408	-15.408	-507.661	11.102	-8.016	-207.988	48.189	23.977	-129.465	-84.369	34.872	-39.148	7.96	-74.766	-28.406	-51.508	-44.8	-24.917	-1.341	-2.024	-1.503	1.5	-1.097
Income Before Tax Numbers are in millions	1,068.69	1,221.097	-160.461	2,723.54	1,457.053	1,330.801	1,955.887	1,736.488	1,496.336	1,795.424	1,733.07	1,417.931	959.859	785.798	555.628	399.099	314.591	225.211	262.166	231.972	215.344	176.475	144.881	128.847	101.151	86.342
Income Before Tax Ratio Numbers are in millions	0.126	0.141	-0.019	0.342	0.107	0.07	0.109	0.108	0.107	0.136	0.138	0.128	0.103	0.12	0.119	0.1	0.092	0.081	0.109	0.158	0.165	0.167	0.156	0.188	0.258	0.341
Income Tax Expense Numbers are in millions	209.634	204.457	180.303	315.925	367.195	327.634	363.955	334.226	277.103	271.754	282.694	251.614	167.776	145.833	96.198	75.465	64.214	62.237	48.464	37.369	40.719	34.257	27.609	25.556	21.621	25.229
Net Income Numbers are in millions	955.586	1,071.072	-340.764	2,358.865	1,125.891	1,001.425	1,545.168	1,376.542	1,176.425	1,478.549	1,368.271	1,100.261	769.203	610.811	450.302	316.706	255.888	177.743	205.5	193.514	171.279	141.188	117.849	102.871	79.53	58.827
Net Income Ratio Numbers are in millions	0.112	0.123	-0.04	0.297	0.083	0.053	0.086	0.086	0.084	0.112	0.109	0.099	0.083	0.093	0.097	0.079	0.075	0.064	0.085	0.132	0.132	0.134	0.127	0.15	0.203	0.233
EPS Numbers are in millions	0.64	0.72	-0.23	1.57	0.75	0.66	1.02	0.91	0.78	0.99	0.94	0.76	0.59	0.42	0.33	0.23	0.19	0.14	0.16	0.15	0.13	0.086	0.072	0.081	0.062	0.046
EPS Diluted Numbers are in millions	0.64	0.72	-0.23	1.57	0.75	0.66	1.02	0.91	0.78	0.99	0.94	0.76	0.59	0.42	0.33	0.23	0.19	0.14	0.16	0.15	0.13	0.086	0.072	0.081	0.062	0.046
EBITDA Numbers are in millions	1,626.17	1,808.532	448.251	3,424.47	2,342.925	2,225.186	2,800.051	2,396.254	2,036.719	2,352.115	2,274.736	1,771.99	1,313.271	978.159	728.627	511.106	502.504	370.671	390.831	335.51	295.055	228.102	181.231	150.442	107.159	89.938
EBITDA Ratio Numbers are in millions	0.191	0.209	0.052	0.431	0.173	0.117	0.156	0.149	0.146	0.178	0.181	0.16	0.141	0.149	0.157	0.128	0.146	0.133	0.162	0.229	0.227	0.216	0.195	0.22	0.274	0.355

Tasly Pharmaceutical Group Co., Ltd

SSE:600535.SS Add to watchlist

SSE:600535.SS